rosuxan 10 mg/1 kapsula+ 100 mg/1 kapsula kapsula, tvrda
farmavita d.o.o. sarajevo - acetilsalicilna kiselina, rosuvastatin - kapsula, tvrda - 10 mg/1 kapsula+ 100 mg/1 kapsula - 1 kapsula, tvrda sadrži: 10,40 mg rosuvastatin kalcijuma što odgovara 10 mg rosuvastatina i 100 mg acetilsalicilne kiseline
rosuxan 20 mg/1 kapsula+ 100 mg/1 kapsula kapsula, tvrda
farmavita d.o.o. sarajevo - acetilsalicilna kiselina, rosuvastatin - kapsula, tvrda - 20 mg/1 kapsula+ 100 mg/1 kapsula - 1 kapsula, tvrda sadrži: 20,80 mg rosuvastatin kalcijuma što odgovara 20 mg rosuvastatina i 100 mg acetilsalicilne kiseline
aspirin plus c 400 mg/1 tableta+ 240 mg/1 tableta šumeća tableta
bayer d.o.o. sarajevo - acetilsalicilna kiselina, askorbinska kiselina - šumeća tableta - 400 mg/1 tableta+ 240 mg/1 tableta - 1 šumeća tableta sadrži: 400 mg acetilsalicilne kiseline 240 mg askorbinske kiseline
acekal c 500 mg + 300 mg šumeći prašak s okusom limuna
fidifarm d.o.o., obrtnička 37, rakitje, bestovje - folna acetylsalicylicum, ascorbicum ацидум - šumeći prašak - 500 mg + 300 mg - urbroj: jedna vrećica sadrži 500 mg acetilsalicilatne kiseline i 300 mg askorbatne kiseline
duoplavin 75 mg/1 tableta+ 100 mg/1 tableta film tableta
amicus pharma d.o.o. - acetilsalicilna kiselina, klopidogrel - film tableta - 75 mg/1 tableta+ 100 mg/1 tableta - 1 film tableta sadrži: 75 mg klopidogrela (u obliku klopidogrelhidrogensulfata) i 100 mg acetilsalicilne kiseline
startina 5 mg/1 kapsula+ 100 mg/1 kapsula kapsula, tvrda
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - acetilsalicilna kiselina, rosuvastatin - kapsula, tvrda - 5 mg/1 kapsula+ 100 mg/1 kapsula - 1 kapsula, tvrda sadrži 5 mg rosuvastatina (u obliku rosuvastatinkalcijuma) i 100 mg acetilsalicilne kiseline
startina 10 mg/1 kapsula+ 100 mg/1 kapsula kapsula, tvrda
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - acetilsalicilna kiselina, rosuvastatin - kapsula, tvrda - 10 mg/1 kapsula+ 100 mg/1 kapsula - 1 kapsula, tvrda sadrži 10 mg rosuvastatina (u obliku rosuvastatinkalcijuma) i 100 mg acetilsalicilne kiseline
startina 20 mg/1 kapsula+ 100 mg/1 kapsula kapsula, tvrda
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - acetilsalicilna kiselina, rosuvastatin - kapsula, tvrda - 20 mg/1 kapsula+ 100 mg/1 kapsula - 1 kapsula, tvrda sadrži 20 mg rosuvastatina (u obliku rosuvastatinkalcijuma) i 100 mg acetilsalicilne kiseline
anbol cardio 75 mg/1 tableta gastrorezistentna tableta
galenika d.o.o. - acetilsalicilna kiselina - gastrorezistentna tableta - 75 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 75 mg acetilsalicilne kiseline
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.